Introduction
Molecular Targeted Therapy for Alzheimer’s Disease is a comprehensive exploration of the molecular mechanisms, pathological pathways, and emerging therapeutic strategies associated with Alzheimer’s disease (AD). Positioned at the intersection of neuroscience, molecular biology, pharmacology, and biotechnology, the book focuses on targeted therapeutic approaches aimed at understanding and managing one of the world’s most complex neurodegenerative disorders.
The book systematically examines major molecular contributors to Alzheimer’s disease, including glutamate and NMDA receptor signalling, tau protein dysfunction, Axl kinase activity, NFAT dysregulation, oxidative stress, neuroinflammation, and microRNA-mediated pathways. It further explores innovative treatment strategies such as nanotechnology-based drug delivery systems, anti-amyloid antibody therapies, immunotherapy, small-molecule therapeutics, natural product-based interventions, and biopolymer-assisted treatment approaches. The concluding chapters discuss integrative molecular and targeted therapeutic frameworks that bridge current discoveries with future innovations in Alzheimer’s disease management.
Key Features
- - Comprehensive coverage of molecular mechanisms underlying Alzheimer’s disease.
- - Detailed discussions of targeted therapeutic and immunotherapeutic strategies.
- - Insights into nanotechnology, small molecules, biopolymers, and natural-product-based treatments.
- - Integration of molecular biology, pharmacology, and computational approaches focuses on emerging innovations and future directions in Alzheimer’s disease therapy.
Target Readership :
Researchers, neuroscientists, pharmacologists, clinicians, postgraduate students, and academics in neuroscience, molecular medicine, biotechnology, pharmacology, and neurodegenerative disease research.